Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine
Martin Sattler, Isa Mambetsariev, Jeremy Fricke, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1936-1936
Open Access | Times Cited: 10

Showing 10 citing articles:

An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
Rohit Pal, Ghanshyam Teli, Sindhuja Sengupta, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9795-9811
Closed Access | Times Cited: 20
Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer
Meisam Bagheri, Gadisti A. Mohamed, Mohammed Ashick Mohamed Saleem, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101504-101504
Open Access | Times Cited: 7
GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells
Fumiya Ito, Wakiko Iwata, Yoshihiro Adachi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
PTEN-Mediated Resistance in Cancer: From Foundation to Future Therapies
Muhammad Tufail
Toxicology Reports (2025) Vol. 14, pp. 101987-101987
Open Access
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer
Martin Sattler, Ravi Salgia
Cell Reports Medicine (2025), pp. 101983-101983
Open Access
From Challenges to Solutions: A Review of Fourth-Generation EGFR Tyrosine Kinase Inhibitors to Overcome the C797S Triple Mutation in Non-Small Cell Lung Cancer
Iqrar Ahmad, Harun Patel
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117178-117178
Closed Access | Times Cited: 3
Fluctuation of Acquired Resistance Mutations and Re-Challenge with EGFR TKI in Metastatic NSCLC: A Case Report
Markus Falk, Stefanie Schatz, Fabian Reich, et al.
Current Oncology (2023) Vol. 30, Iss. 10, pp. 8865-8871
Open Access | Times Cited: 1
Covalent Inhibitors of MAP Kinases
Surya K. De
Drug design and discovery (2024), pp. 159-189
Closed Access
On the Virtues of “Team Medicine”—A City of Hope Perspective
Prakash Kulkarni, Ravi Salgia
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 4897-4897
Open Access
LINC01572 is a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma
Yaolin Zheng, Zhenshan Zhang, Xueyan Li, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access
Page 1

Scroll to top